Earnings are out
MESO · NASDAQ · Biotechnology

Mesoblast (ADR)

Develops FDA-approved Ryoncil for pediatric steroid-refractory acute graft-versus-host disease.

$17.44
After-hours close−0.03 (−0.17%)
At close$17.47(−3.91%)

Breakdown13F · Form 4

Institutions 2.53%Insiders

Shares outstanding 129.70M · Float 83.68M · 64.5% free float

Insiders — filings are in the shares behind the receipt.

This listing is a depositary receipt and the Form 4 positions here are filed in the shares behind it, a different unit from the share count and in a ratio the filings never state, so no insider percentage is shown.

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
George, Gregory288.52M22.36%13GMar 11, 2026
Gueck William J.64.52M5.00%13GSep 16, 2025
BlackRock, Inc.630.9K0.49%13FMay 13, 2026
Morgan Stanley514.4K0.40%13FMay 15, 2026
Goldman Sachs Group Inc397.2K0.31%13FMay 15, 2026

Institutions13F, as of Mar 31, 2026

75 holders · 3.29M shares · 9 new positions · 36 increased · 15 reduced · 15 closed

HolderShares% outstandingChg q/qFiled
BlackRock, Inc.630.9K0.49%−45.5KMay 13, 2026
Morgan Stanley514.4K0.40%−82.5KMay 15, 2026
Goldman Sachs Group Inc397.2K0.31%+1.4KMay 15, 2026
Susquehanna International Group, LLP386.5K0.30%−43.4KMay 15, 2026
UBS Group AG132.6K0.10%+60.0KMay 5, 2026
Bank of America Corp /DE/100.0K0.08%+85.9KMay 18, 2026
Jane Street Group, LLC98.8K0.08%−68.6KMay 12, 2026
Penbrook Management LLC87.1K0.07%−500Apr 21, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
George, Gregory22.36%288.52M13GMar 11, 2026
Gregory George21.59%275.85M13GSep 12, 2025
Gueck William J.5.00%64.52M13GSep 16, 2025

InsidersForm 4

No current Form 4 position on record.

8 positions are filed in the unlisted share unit (225.22M shares), which no share count here divides

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Apr 9, 2026
Gregory Georgedirector, 10 percent owner:
Purchase · 19 lots2,131,890$4.9313,586,890
Apr 10, 2026
Gregory Georgedirector, 10 percent owner:
Purchase2,324,072$1.488,324,072
Apr 4, 2026
Gregory Georgedirector, 10 percent owner:
Purchase4,000,000$1.4212,000,000

CongressHouse and Senate disclosures

Not reported.